| By Vlad Skutelnik | | Macroaxis Story | |
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
This list of potential positions covers Funds investing in healthcare. Funds or Etfs investing in medical and healthcare goods or services as well as hospital management or maintenance organizations in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using
Portfolio Positions Ratings and
Equity Ratings tools to further calibrate your research.
Story appears to be empty
Allianzgi Health Sciences (RAGHX)
Allianzgi Health Sciences [RAGHX] is traded in USA and was established 29th of March 2024. Allianzgi Health is listed under Allianz Global Investors category by Fama And French industry classification. The fund is listed under Health category and is part of
Allianz Global Investors family. The entity is thematically classified as
Healthcare Funds. This fund at this time has accumulated 175.34
M in
assets with no minimum investment requirementsAllianzgi Health Sciences is currently producing year-to-date (YTD) return of 8.22%, while the total return for the last 3 years was 6.0%. At this time, the entity appears to be
undervalued.
Allianzgi Health Sciences shows a prevailing
Real Value of $34.07 per share. The current price of the fund is $31.11. We determine the value of
Allianzgi Health Sciences from analyzing fund
fundamentals and
technical indicators as well as its
Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing
real values will blend.
Biotechnology Fund Investor (RYOIX)
Biotechnology Fund Investor [RYOIX] is traded in USA and was established 29th of March 2024. Biotechnology Fund is listed under Rydex Funds category by Fama And French industry classification. The fund is listed under Health category and is part of
Rydex Funds family. This fund at this time has accumulated 117.21
M in
assets with no minimum investment requirementsBiotechnology Fund is currently producing year-to-date (YTD) return of 1.46%, while the total return for the last 3 years was -0.89%.
Deutsche Health And (SCHLX)
Deutsche Health And [SCHLX] is traded in USA and was established 29th of March 2024. The fund is listed under Health category and is part of
DWS family. The entity is thematically classified as
Healthcare Funds. This fund at this time has accumulated 318.86
M in
assets with no minimum investment requirementsDeutsche Health And is currently producing year-to-date (YTD) return of 6.36%, while the total return for the last 3 years was 6.55%. At this time, the entity appears to be
fairly valued.
Deutsche Health And shows a prevailing
Real Value of $42.35 per share. The current price of the fund is $42.7. We determine the value of
Deutsche Health And from reviewing fund
fundamentals and
technical indicators as well as its
Probability Of Bankruptcy. In general, we advise acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing
real values will submerge.
First Trust Nasdaq (FTXH)
First Trust Nasdaq [FTXH] is traded in USA and was established 2016-09-20. The fund is listed under
Health category and is part of
First Trust family. The entity is thematically classified as
Health Care ETFs. First Trust Nasdaq currently have 36.04
M in assets under management (AUM). , while the total return for the last 3 years was 4.5%.
Invesco Dynamic Pharmaceuticals (PJP)
Invesco Dynamic Pharmaceuticals [PJP] is traded in USA and was established 2005-06-23. The fund is classified under
Health category within
Invesco family. The entity is thematically classified as
Health Care ETFs. Invesco Dynamic Phar at this time have 302.14
M in assets. , while the total return for the last 3 years was 1.4%.
SPDR SP Pharmaceuticals (XPH)
SPDR SP Pharmaceuticals [XPH] is traded in USA and was established 2006-06-19. The fund is classified under
Health category within
SPDR State Street Global Advisors family. The entity is thematically classified as
Health Care ETFs. SPDR SP Pharmaceuticals at this time have 206.63
M in net assets. , while the total return for the last 3 years was -3.6%.
Current Healthcare Funds Recommendations
Story appears to be empty
Allianzgi Health Sciences (RAGHX)
Allianzgi Health Sciences [RAGHX] is traded in USA and was established 29th of March 2024. Allianzgi Health is listed under Allianz Global Investors category by Fama And French industry classification. The fund is listed under Health category and is part of
Allianz Global Investors family. The entity is thematically classified as
Healthcare Funds. This fund at this time has accumulated 175.34
M in
assets with no minimum investment requirementsAllianzgi Health Sciences is currently producing year-to-date (YTD) return of 8.22%, while the total return for the last 3 years was 6.0%. At this time, the entity appears to be
undervalued.
Allianzgi Health Sciences shows a prevailing
Real Value of $34.07 per share. The current price of the fund is $31.11. We determine the value of
Allianzgi Health Sciences from analyzing fund
fundamentals and
technical indicators as well as its
Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing
real values will blend.
Biotechnology Fund Investor (RYOIX)
Biotechnology Fund Investor [RYOIX] is traded in USA and was established 29th of March 2024. Biotechnology Fund is listed under Rydex Funds category by Fama And French industry classification. The fund is listed under Health category and is part of
Rydex Funds family. This fund at this time has accumulated 117.21
M in
assets with no minimum investment requirementsBiotechnology Fund is currently producing year-to-date (YTD) return of 1.46%, while the total return for the last 3 years was -0.89%.
Deutsche Health And (SCHLX)
Deutsche Health And [SCHLX] is traded in USA and was established 29th of March 2024. The fund is listed under Health category and is part of
DWS family. The entity is thematically classified as
Healthcare Funds. This fund at this time has accumulated 318.86
M in
assets with no minimum investment requirementsDeutsche Health And is currently producing year-to-date (YTD) return of 6.36%, while the total return for the last 3 years was 6.55%. At this time, the entity appears to be
fairly valued.
Deutsche Health And shows a prevailing
Real Value of $42.35 per share. The current price of the fund is $42.7. We determine the value of
Deutsche Health And from reviewing fund
fundamentals and
technical indicators as well as its
Probability Of Bankruptcy. In general, we advise acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing
real values will submerge.
First Trust Nasdaq (FTXH)
First Trust Nasdaq [FTXH] is traded in USA and was established 2016-09-20. The fund is listed under
Health category and is part of
First Trust family. The entity is thematically classified as
Health Care ETFs. First Trust Nasdaq currently have 36.04
M in assets under management (AUM). , while the total return for the last 3 years was 4.5%.
Invesco Dynamic Pharmaceuticals (PJP)
Invesco Dynamic Pharmaceuticals [PJP] is traded in USA and was established 2005-06-23. The fund is classified under
Health category within
Invesco family. The entity is thematically classified as
Health Care ETFs. Invesco Dynamic Phar at this time have 302.14
M in assets. , while the total return for the last 3 years was 1.4%.
SPDR SP Pharmaceuticals (XPH)
SPDR SP Pharmaceuticals [XPH] is traded in USA and was established 2006-06-19. The fund is classified under
Health category within
SPDR State Street Global Advisors family. The entity is thematically classified as
Health Care ETFs. SPDR SP Pharmaceuticals at this time have 206.63
M in net assets. , while the total return for the last 3 years was -3.6%.
Current Healthcare Funds Recommendations
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com